An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies

Summary

The study objective of this open label, multicenter study is to provide access to NKTR-102 treatment to subjects previously enrolled in a NKTR-102 study who are without signs of disease progression since receiving NKTR-102. In addition the study will evaluate the safety of continued exposure to NKTR-102, observe disease status and survival status in subjects receiving NKTR-102, and evaluate the efficacy of NKTR-102 in subjects with advanced or metastatic solid tumors.

Timeline

Start

2011-10

Primary completion

2017-08

Completion

2017-11

Drugs

Indications